Want to track COPN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cosmo Pharmaceuticals N.V. (COPN) Statistics
Valuation metrics
Market Cap 1B
Enterprise value 1.22B
Trailing P/E (ttm) -327.43
Forward P/E -
PEG ratio 3.18
Price/Sales (ttm) 12.16
Price/Book (mrq) 2.45
Enterprise Value/Revenue 11.66
Enterprise Value/EBITDA 172.52
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 45.38K
Average volume (90 days) 46.81K
Price summary
52-Week low 53.4
52-Week high 129.4
Beta -
50-Day moving average 74.33
200-Day moving average 94.53
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2.1
Trailing annual dividend yield 0.0284%
5-Year annual dividend yield -
Payout ratio -8.99
Dividend Date 11 May 2026
Ex-Dividend Date 24 Apr 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.03%
Operating margin -0.05%
Operational effectiveness
Return on assets -0.01%
Return on equity -0.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 6.53
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.23
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.68
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 7.18%
Book value per share (mrq) 30.61
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
